- Home
- / PetLife Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PetLife Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2022-08-02
Market Capitalization
$7.9 M
2022-08-02
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|
| Cost of goods sold | 523.1K | 60.1K | 220.7K | |||
| Gross profit | (60.1K) | |||||
| General and administrative expense | 830.6K | 692.4K | 1.4M | 1.7M | 3.7M | 1.3M |
| Operating expense total | 830.6K | 692.4K | 1.5M | 1.7M | 3.7M | 1.3M |
| EBIT | (886.6K) | (1.7M) | (1.5M) | (1.9M) | (3.7M) | (22.7M) |
| Interest expense | 5.2K | |||||
| Pre tax profit | (630.1K) | |||||
| Net Income | (630.1K) | (1.2M) | (1.5M) | (1.9M) | (3.7M) | (23.3M) |